Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 82/100Confidence medium
medrxiv2026-09-08mtDNAophthalmologybiomarkersneurobiology

Lower blood mitochondrial DNA copy number tracks faster visual-field loss in open-angle glaucoma

In 200 people with primary open-angle glaucoma followed for about 11 years, fewer mitochondrial DNA copies in blood leukocytes associate with a steeper slide in visual-field mean deviation. The link is strongest when peak intraocular pressure is not the obvious villain, which makes systemic mtDNA copy number a candidate reserve marker, not a pressure surrogate.

Mito.news · at a glance

Signal profile (abstract-level)

mtDNA · ophthalmology · biomarkers · neurobiology

Score 82/100MEDRXIVmedium confidencemtDNA
82
Importance
60
Mito signal
53
Dysfunction
75
Evidence
50
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Finding. Among 200 people with primary open-angle glaucoma watched for about 11 years, the ones with fewer mitochondrial DNA copies in their white cells lost visual field faster. Pham, Medeiros and colleagues counted genomes with a TaqMan pair, cytochrome b against beta-2 microglobulin. Mean copy number was 107.6 per cell (interquartile range 70.5 to 126.7). On a log scale, more copies lined up with a slower mean-deviation slide (univariable beta 0.29). The association was loudest when peak intraocular pressure was lower, which is the opposite of “this is just a high-pressure cohort in disguise.”

Why this paper matters

Glaucoma is often sold as plumbing: pressure, cup, field. A lot of optic nerves still die at ordinary pressures. Mitochondrial genomic reserve is one of the stories the field uses for that remainder. This study gives the story a clinical time axis, not a single-visit correlation. A decade of standard automated perimetry is the right endpoint if you care about what patients lose.

It is also honest about what was counted. Blood is not retina. Cytochrome b is not a ganglion-cell biopsy. The claim is systemic biomarker of susceptibility, which is weaker than “the nerve is running out of mtDNA” and more usable in a clinic that already draws blood.

How to read the score

Low eighties. Real mtDNA, real longitudinal fields, a pressure interaction that makes biological sense if copy number is reserve rather than IOP residue. Confidence is medium because the abstract as posted is truncated in the results and because leukocyte mix can fake copy-number biology.

Caveats

Do not treat 107.6 as a universal normal. Do not start mito-boosting supplements from a retrospective slope. Read the full multivariable table in the preprint before you quote p-values this brief cannot see.

What to do with it

If you collect mitochondrial biomarkers in neurodegeneration, POAG belongs next to the usual optic-neuropathy set. If you build risk models, test mtDNA copy number where peak IOP is unimpressive. If you want mechanism, the next tissue is the optic nerve head, not another leukocyte qPCR without cell-sort.

Free HTML is above. Bots pay for JSON at /api/v1/papers/10-64898-2026-09-05-26362328. Optional wallet tester: MetaMask ($0.005).

Source preprint

Mitochondrial DNA Copy Number Is Associated With Visual Field Progression in Primary Open-Angle Glaucoma

10.64898/2026.09.05.26362328

Pham AH, Kane KM, da Costa DR, Medeiros FA.

Related briefs